Refine a Trial

Help: Refine a Trial

Help: Refine a Trial

Welcome to the Vital Crowd research protocol builder! 

This tool is designed to walk you through the process of giving us your insights into the design of health care research. It’s pretty easy to get the hang of it, but here are the basics:

Each of the circles below represents an important element in the design of health research. while the specifics change from study to study, the basic elements are consistent throughout most health research.

The researchers who want your input have started the process of scoping out the research design, but they need your input to make it better.

Each element is different in important ways but taken together, they form a cohesive research protocol, which will help uncover important findings about health and care.

When you click on a trial “element”, the box to the right will display the current thinking of the researchers who have drafted this trial’s protocol. Once you’ve read through the overview for that element of the trial, you have three options:

If you love what’s described and have no changes, you can ‘like’that draft element by clicking the ‘heart’ icon.

  • If you have a better idea or want to refine what the researchers have proposed, click on the ‘make this better’tab. This will open a text box, where you can give your own ideas or suggestions to the researchers for what you think would work better or be more helpful.
  • Once you’ve added your insights, you can see what others have added and comment, add to or refine their suggestions or give a thumbs up for the suggestions that other members have made.

Each time you complete a task or somebody likes your ideas, you earn a point. You can see your point tallies at the bottom of the page.

You might want to start by clicking through each circle to get a sense of each of the elements and how the researchers envision them working together.

Then it’s time to dive in.

Trial Overview 

Patients who use insulin frequently experience a substantial amount of glycemic variability. On any given day, insulin users can experience extreme high glucose and extreme low glucose levels. Even if the variations aren’t extreme, the ups and downs and the wide variations in glucose levels take their toll on the lives of patients, often impacting mood, the ability to function, think clearly and exercise regularly. 

The current “gold standard” for measuring diabetes control, Hb A1C, does not reflect the glycemic variability that impacts the ability of patients to live a healthy, functioning life.  Patients need a better measure, which more accurately reflects the impact of glycemic changes on their ability to function and their quality of life.

In recent years, new drugs developed to treat type 2 diabetes have been found to help some type 1 diabetes patients maintain their glucose levels with fewer extreme highs or significant variations. This study will assess the impact of these newer drugs, specifically GLP-1 Analogs and Incretin Mimetics, to help decrease the amount of glycemic variability experienced by patients. 

The study will use the methodology developed in the companion study being refined on VitalCrowd “Glycemic Variability Methodology”.

Help Improve This
View Discussion